Novas perspectivas no Tratamento do Herpes Simples

Bibliographic Details
Main Author: Santos, Omar Lupi da Rosa
Publication Date: 1995
Other Authors: Silva, Ângela Gonçalves da, Pereira Jr, Antônio Carlos
Format: Article
Language: por
Source: DST (Niterói. Online)
Download full: https://www.bjstd.org/revista/article/view/107
Summary: ln the developed countries the increasing seroprevalence of herpes simplex vims (HSV) is very relevant, particularly because the large proportion of asymptomatic infected individuals. For patients who are symptomatic there is considerable individual variation in the pattern and severity of recurrences. Selective antivirai agents have plàyed a crucial role in the treatment of this disease. Acyclovir has been shown to be effective for the treatmenr of individual ep1sodes as well as a long-term supressive therapy. New acyclovir analogues líke velaciclovir and famciclovir have an improved oral bioavailability and a better activity against the less sensitive viruses. We analise some types of treatment of herpes simplex, particularly tbe purine analogues and vaccines against HSV.
id SBDST_cc38b0c7d19732f72ef4a984091f9ea3
oai_identifier_str oai:ojs.bjstd.org:article/107
network_acronym_str SBDST
network_name_str DST (Niterói. Online)
repository_id_str
spelling Novas perspectivas no Tratamento do Herpes Simplesvíms herpes simplesterapêuticaaciclovirherpes simplex virustherapyacyclovirln the developed countries the increasing seroprevalence of herpes simplex vims (HSV) is very relevant, particularly because the large proportion of asymptomatic infected individuals. For patients who are symptomatic there is considerable individual variation in the pattern and severity of recurrences. Selective antivirai agents have plàyed a crucial role in the treatment of this disease. Acyclovir has been shown to be effective for the treatmenr of individual ep1sodes as well as a long-term supressive therapy. New acyclovir analogues líke velaciclovir and famciclovir have an improved oral bioavailability and a better activity against the less sensitive viruses. We analise some types of treatment of herpes simplex, particularly tbe purine analogues and vaccines against HSV.As taxas crescentes de soroprevalência para o herpes simples vírus (HSV) são preocupantes nos países desenvolvidos. Uma grande parcela dos indivíduos portadores do vírus e assi ntornático. Os portadores sintomáticos da moléstia apresentam uma vasta gama de sintomatologia clínica e severidade das recorrências. Agentes antivirais seletivos têm participado ativamente no tratamento da doença. O aciclovir demonstrou ser efetivo no tratamento dos episódios individuais, bem como na terapia supressiva de longo termo. Novos análogos do aciclovir como o velaciclovir e o famciclovir apresentam uma atividade biológica mais elevada e uma melhor atividade contra cepas virais mas resistentes. Analisamos algumas abordagens terapêuticas ao herpes simples, com destaque especial para os análogos das purinas e para as vacinas anti-herpeticas.Sociedade Brasileira de Doenças Sexualmente Transmissíveis1995-09-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.bjstd.org/revista/article/view/107Brazilian Journal of Sexually Transmitted Diseases; Vol. 7 No. 3 (1995); 9-12Brazilian Journal of Sexually Transmitted Diseases; v. 7 n. 3 (1995); 9-122177-8264reponame:DST (Niterói. Online)instname:Sociedade Brasileira de Doenças Sexualmente Transmissíveisinstacron:SBDSTporhttps://www.bjstd.org/revista/article/view/107/94Santos, Omar Lupi da RosaSilva, Ângela Gonçalves daPereira Jr, Antônio Carlosinfo:eu-repo/semantics/openAccess2021-11-11T14:34:12Zoai:ojs.bjstd.org:article/107Revistahttps://www.bjstd.org/revistaONGhttps://www.bjstd.org/revista/oaimaurodst@gmail.com | producao@zeppelini.com.br | secretaria@zeppelini.com.br2177-82640103-4065opendoar:2021-11-11T14:34:12DST (Niterói. Online) - Sociedade Brasileira de Doenças Sexualmente Transmissíveisfalse
dc.title.none.fl_str_mv Novas perspectivas no Tratamento do Herpes Simples
title Novas perspectivas no Tratamento do Herpes Simples
spellingShingle Novas perspectivas no Tratamento do Herpes Simples
Santos, Omar Lupi da Rosa
víms herpes simples
terapêutica
aciclovir
herpes simplex virus
therapy
acyclovir
title_short Novas perspectivas no Tratamento do Herpes Simples
title_full Novas perspectivas no Tratamento do Herpes Simples
title_fullStr Novas perspectivas no Tratamento do Herpes Simples
title_full_unstemmed Novas perspectivas no Tratamento do Herpes Simples
title_sort Novas perspectivas no Tratamento do Herpes Simples
author Santos, Omar Lupi da Rosa
author_facet Santos, Omar Lupi da Rosa
Silva, Ângela Gonçalves da
Pereira Jr, Antônio Carlos
author_role author
author2 Silva, Ângela Gonçalves da
Pereira Jr, Antônio Carlos
author2_role author
author
dc.contributor.author.fl_str_mv Santos, Omar Lupi da Rosa
Silva, Ângela Gonçalves da
Pereira Jr, Antônio Carlos
dc.subject.por.fl_str_mv víms herpes simples
terapêutica
aciclovir
herpes simplex virus
therapy
acyclovir
topic víms herpes simples
terapêutica
aciclovir
herpes simplex virus
therapy
acyclovir
description ln the developed countries the increasing seroprevalence of herpes simplex vims (HSV) is very relevant, particularly because the large proportion of asymptomatic infected individuals. For patients who are symptomatic there is considerable individual variation in the pattern and severity of recurrences. Selective antivirai agents have plàyed a crucial role in the treatment of this disease. Acyclovir has been shown to be effective for the treatmenr of individual ep1sodes as well as a long-term supressive therapy. New acyclovir analogues líke velaciclovir and famciclovir have an improved oral bioavailability and a better activity against the less sensitive viruses. We analise some types of treatment of herpes simplex, particularly tbe purine analogues and vaccines against HSV.
publishDate 1995
dc.date.none.fl_str_mv 1995-09-09
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.bjstd.org/revista/article/view/107
url https://www.bjstd.org/revista/article/view/107
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.bjstd.org/revista/article/view/107/94
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Brasileira de Doenças Sexualmente Transmissíveis
publisher.none.fl_str_mv Sociedade Brasileira de Doenças Sexualmente Transmissíveis
dc.source.none.fl_str_mv Brazilian Journal of Sexually Transmitted Diseases; Vol. 7 No. 3 (1995); 9-12
Brazilian Journal of Sexually Transmitted Diseases; v. 7 n. 3 (1995); 9-12
2177-8264
reponame:DST (Niterói. Online)
instname:Sociedade Brasileira de Doenças Sexualmente Transmissíveis
instacron:SBDST
instname_str Sociedade Brasileira de Doenças Sexualmente Transmissíveis
instacron_str SBDST
institution SBDST
reponame_str DST (Niterói. Online)
collection DST (Niterói. Online)
repository.name.fl_str_mv DST (Niterói. Online) - Sociedade Brasileira de Doenças Sexualmente Transmissíveis
repository.mail.fl_str_mv maurodst@gmail.com | producao@zeppelini.com.br | secretaria@zeppelini.com.br
_version_ 1838631772564226048

Similar Items